Medtronic seeks PMA for insulin pump/glucose monitor combo; Brown University develops fast-flu detection diagnostic;

 @FierceMedDev: Only a few weeks left to submit your nominations for the 15 fiercest private device developers. Survey | Follow @FierceMedDev

> Medtronic ($MDT) has filed a PMA application seeking FDA approval for an integrated insulin pump and continuous glucose monitor that would suspend insulin delivery if the sensor glucose value is equal to or lower than the threshold value. Release

> Brown University scientists have developed a prototype, fast flu-detection test that can be carried in a first-aid kit, technology that could lead to real-time tracking of influenza. Release

> Mevion Medical has secured 510(k) clearance for its S250 proton therapy system, designed to treat tumors with a smaller, more economically viable device for delivering the treatment. News

> Finland's Nextstim Oy has gained FDA clearance for a new tech module to be used with its navigated brain stimulation system, which allows for mapping of the motor areas of the brain before neurosurgery. Release

> Acacia Research has acquired 7 medtech patent portfolios, including 150 individual patents and pending applications, in areas including medical devices, diagnostics and biologics. Release

Biotech News

 @FierceBiotech: Pharma rocks many Twitter handles for many reasons. Story | Follow @FierceBiotech

 @RyanMFierce: Hi all, we're about to launch FierceBiotech's Fierce 15 biotech search. Countdown from 10... Survey | Follow @RyanMFierce

 @JohnCFierce: ADA roundup: J&J's diabetes pioneer edges out Januvia in Phase III. Data looks pretty good, actually. More | Follow @JohnCFierce

> BioSante preps for two more PhIII LibiGel trials. News

> Special event: Improving the lousy odds on drug development. More

> Merck Serono staffers mull strike as budget ax hovers over Geneva HQ. Article

> Protalix scores $25M milestone from Pfizer. Story

Pharma News

 @FiercePharma: J&J to pay up to $2.2B in Risperdal settlement, Bloomberg says. Close to Pfizer's record $2.3B deal. More | Follow @FiercePharma

> FDA approves Roche's pricey new Herceptin partner, Perjeta. Story

> Who's the sheriff in lab-diagnostics town? More

> China now carries a big compulsory-licensing stick. Article

> Republicans make issue of pharma-backed ads for Obamacare. News

Biotech IT News

> Biogen vet tapped as CIO of Harvard Med School. News

> Novartis predicts drug side effects with computers. Story

> Lilly leads docs to cancer drug trials with iPad app. Article

And Finally...  More than 30% of birth mothers in 2007 had a body mass index exceeding 30kg/m2, which is considered the effective limit for existing non-invasive fetal monitoring technology, according to a new national survey cited by MindChild Medical. Release

Suggested Articles

The ADDF announced its second round of research awards, with a total of $6 million in new funding for diagnostic tests.

Takeda teamed up with Enzyre to develop an at-home diagnostic device that will help people with hemophilia determine their own coagulation status.

Foundation Medicine received a diagnostic approval from the FDA for selecting HR+/HER2- breast cancer patients for treatment with Novartis' Piqray.